• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRPM8 作为胰腺腺癌增殖的潜在生物标志物的遗传和免疫鉴定及功能分析。

Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation.

机构信息

Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, China.

School of Medicine, Southeast University, Nanjing, Jiangsu, China.

出版信息

Cancer Rep (Hoboken). 2024 Jun;7(6):e2108. doi: 10.1002/cnr2.2108.

DOI:10.1002/cnr2.2108
PMID:38837874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11150080/
Abstract

BACKGROUND

Pancreatic adenocarcinoma (PAAD), a member of highly lethal malignant tumors, has a poor outcome and extremely poor prognosis. The transient receptor potential (TRP) superfamily, a group of nonselective cation channels, is capable of influencing cellular functions by regulating calcium homeostasis. In addition, it has been shown that TRP channels can also affect various cellular phenotypes by regulating gene transcription levels and are involved in the development of a variety of malignant tumors.

AIMS

In order to find new therapeutic targets and biomarkers to improve the clinical prognosis of pancreatic cancer, we performed genetic and immunological characterization of TRP channels in PAAD, as well as related functional and prognostic analyses.

METHODS AND RESULTS

We investigated the expression, genetic alterations, methylation levels, and immune infiltration levels of TRP channels in PAAD, and further also analyzed the function of TRP channels in PAAD and their prognostic value for PAAD patients. Our results suggest that TRPM8 may contribute to tumor proliferation by controlling the PI3K-AKT-mTOR signaling pathway in PAAD.

CONCLUSION

After careful evaluation of the accumulated data, we concluded that TRPM8 has potential as a prognostic indicator and prospective therapeutic target in PAAD.

摘要

背景

胰腺导管腺癌(PAAD)是高度致命的恶性肿瘤之一,其预后极差。瞬时受体电位(TRP)超家族是一组非选择性阳离子通道,能够通过调节钙稳态来影响细胞功能。此外,已经表明 TRP 通道还可以通过调节基因转录水平来影响各种细胞表型,并参与多种恶性肿瘤的发生发展。

目的

为了寻找新的治疗靶点和生物标志物来改善胰腺癌的临床预后,我们对 PAAD 中的 TRP 通道进行了遗传和免疫特征分析,并进行了相关的功能和预后分析。

方法和结果

我们研究了 TRP 通道在 PAAD 中的表达、遗传改变、甲基化水平和免疫浸润水平,并进一步分析了 TRP 通道在 PAAD 中的功能及其对 PAAD 患者的预后价值。我们的研究结果表明,TRPM8 可能通过控制 PI3K-AKT-mTOR 信号通路促进 PAAD 中的肿瘤增殖。

结论

在仔细评估了积累的数据后,我们得出结论,TRPM8 可能成为 PAAD 中的一个有预后价值的指标和有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/99d4a41f0ecf/CNR2-7-e2108-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/fd71dd62ddfc/CNR2-7-e2108-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/ac0b7a664ad6/CNR2-7-e2108-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/365209387a78/CNR2-7-e2108-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/67f13fe8a9b2/CNR2-7-e2108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/2d2920d22dd5/CNR2-7-e2108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/36f07e6bb1a0/CNR2-7-e2108-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/ecd7e76fbfd0/CNR2-7-e2108-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/6d3da37a2c49/CNR2-7-e2108-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/99d4a41f0ecf/CNR2-7-e2108-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/fd71dd62ddfc/CNR2-7-e2108-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/ac0b7a664ad6/CNR2-7-e2108-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/365209387a78/CNR2-7-e2108-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/67f13fe8a9b2/CNR2-7-e2108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/2d2920d22dd5/CNR2-7-e2108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/36f07e6bb1a0/CNR2-7-e2108-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/ecd7e76fbfd0/CNR2-7-e2108-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/6d3da37a2c49/CNR2-7-e2108-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/11150080/99d4a41f0ecf/CNR2-7-e2108-g008.jpg

相似文献

1
Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation.TRPM8 作为胰腺腺癌增殖的潜在生物标志物的遗传和免疫鉴定及功能分析。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2108. doi: 10.1002/cnr2.2108.
2
A prognostic biomarker of disulfidptosis constructed by machine learning framework model as potential reporters of pancreatic adenocarcinoma.基于机器学习框架模型构建的二硫键化程序性死亡生物标志物,作为胰腺腺癌的潜在报告者。
Cell Signal. 2024 Nov;123:111371. doi: 10.1016/j.cellsig.2024.111371. Epub 2024 Aug 28.
3
PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC.PLAGL2作为胰腺癌的一种预后生物标志物和上皮-间质转化促进因子。
Sci Rep. 2025 Jul 14;15(1):25425. doi: 10.1038/s41598-025-09591-x.
4
Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma.生物信息学分析表明,在胰腺腺癌中,NT5M通过CXCL8经由程序性死亡受体配体1(PD-L1)调节免疫逃逸。
Sci Rep. 2025 Jul 19;15(1):26207. doi: 10.1038/s41598-025-10098-8.
5
Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling.过表达的 CA12 在胰腺癌中有预后价值,并通过 NF-κB 信号通路促进肿瘤细胞凋亡。
J Cancer Res Clin Oncol. 2021 May;147(5):1557-1564. doi: 10.1007/s00432-020-03447-9. Epub 2021 Jan 2.
6
Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met Gene.揭示橙皮素和大黄素联合治疗对抑制胰腺癌进展及针对C-Met基因的潜在作用。
Protein Pept Lett. 2025;32(4):280-298. doi: 10.2174/0109298665363165250225100109.
7
Comprehensive exploration of immune checkpoint-related genes in the prognosis and tumor immune microenvironment of pancreatic adenocarcinoma.全面探讨免疫检查点相关基因在胰腺腺癌预后和肿瘤免疫微环境中的作用。
Clinics (Sao Paulo). 2024 Aug 28;79:100481. doi: 10.1016/j.clinsp.2024.100481. eCollection 2024.
8
The landscape of long non-coding RNA during cSCC progression.皮肤鳞状细胞癌进展过程中长链非编码RNA的情况
Br J Dermatol. 2025 Mar 27. doi: 10.1093/bjd/ljaf108.
9
Ferroptosis-related LINC02535/has-miR-30c-5p/EIF2S1 axis as a novel prognostic biomarker involved in immune infiltration and progression of PDAC.铁死亡相关 LINC02535/has-miR-30c-5p/EIF2S1 轴作为一种新的预后生物标志物,参与 PDAC 的免疫浸润和进展。
Cell Signal. 2024 Nov;123:111338. doi: 10.1016/j.cellsig.2024.111338. Epub 2024 Aug 6.
10
Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.自噬相关的CMTM6 通过激活 Wnt/β-catenin 通路促进胶质母细胞瘤的进展,并作为一种癌免疫生物学标志物。
J Gene Med. 2024 May;26(5):e3685. doi: 10.1002/jgm.3685.

引用本文的文献

1
Enhanced anti-cancer effect of AMTB hydrochloride via chitosan nanoparticles in pancreatic cancer.盐酸AMTB通过壳聚糖纳米粒对胰腺癌的抗癌作用增强。
BMC Cancer. 2025 May 26;25(1):944. doi: 10.1186/s12885-025-14356-w.
2
TRP channels and breast cancer: the role of TRPs in the pathophysiological development.瞬时受体电位通道与乳腺癌:瞬时受体电位通道在病理生理发展中的作用
Front Mol Biosci. 2025 Feb 26;12:1528663. doi: 10.3389/fmolb.2025.1528663. eCollection 2025.

本文引用的文献

1
The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision.基因间型长链非编码RNA(LINC RNA)在癌症中的研究现状及对LINC00511的定向观察:迈向非编码RNA精准医学的一步
Noncoding RNA. 2023 Sep 25;9(5):58. doi: 10.3390/ncrna9050058.
2
Pancreatic cancer: Advances and challenges.胰腺癌:进展与挑战。
Cell. 2023 Apr 13;186(8):1729-1754. doi: 10.1016/j.cell.2023.02.014.
3
Suppressive effects of a transient receptor potential melastatin 8 (TRPM8) agonist on hyperthermia-induced febrile seizures in infant mice.
瞬时受体电位香草酸亚型8(TRPM8)激动剂对幼鼠热诱导热性惊厥的抑制作用。
Front Pharmacol. 2023 Mar 9;14:1138673. doi: 10.3389/fphar.2023.1138673. eCollection 2023.
4
Irritant-evoked reflex tachyarrhythmia in spontaneously hypertensive rats is reduced by inhalation of TRPM8 agonists l-menthol and WS-12.TRPM8 激动剂薄荷醇和 WS-12 吸入可减少自发性高血压大鼠的刺激性诱发反射性心动过速。
J Appl Physiol (1985). 2023 Feb 1;134(2):307-315. doi: 10.1152/japplphysiol.00495.2022. Epub 2023 Jan 5.
5
A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers.基于泛癌症生物信息学的 TRPM7 在癌症中的文献综述。
Pharmacol Ther. 2022 Dec;240:108302. doi: 10.1016/j.pharmthera.2022.108302. Epub 2022 Nov 1.
6
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies.胰腺癌:当前治疗方法与新型疗法综述
J Invest Surg. 2023 Dec 31;36(1):2129884. doi: 10.1080/08941939.2022.2129884. Epub 2022 Oct 3.
7
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling.TRPM8 表明结直肠癌患者预后不良,其药物靶向治疗通过抑制 Wnt/β-catenin 信号通路减少小鼠肿瘤生长。
Br J Pharmacol. 2023 Jan;180(2):235-251. doi: 10.1111/bph.15960. Epub 2022 Oct 17.
8
TRPC1 correlates with poor tumor features, radiotherapy efficacy and survival in tongue squamous cell carcinoma.TRPC1 与舌鳞状细胞癌的不良肿瘤特征、放疗疗效和生存相关。
Biomark Med. 2022 Aug;16(11):867-877. doi: 10.2217/bmm-2021-0208. Epub 2022 Jul 14.
9
The LCK-14-3-3ζ-TRPM8 axis regulates TRPM8 function/assembly and promotes pancreatic cancer malignancy.LCK-14-3-3ζ-TRPM8 轴调节 TRPM8 功能/组装并促进胰腺癌恶性转化。
Cell Death Dis. 2022 Jun 4;13(6):524. doi: 10.1038/s41419-022-04977-5.
10
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.新型 TRPM8 阻断剂对去势抵抗性前列腺癌模型发挥抗癌活性。
Eur J Med Chem. 2022 Aug 5;238:114435. doi: 10.1016/j.ejmech.2022.114435. Epub 2022 May 12.